4.7 Article

Randomized Selection Design Trial Evaluating CD8+-Enriched Versus Unselected Tumor-Infiltrating Lymphocytes for Adoptive Cell Therapy for Patients With Melanoma

Related references

Note: Only part of the references are listed.
Review Biotechnology & Applied Microbiology

Will T-cell therapy for cancer ever be a standard of care?

M. K. Brenner

CANCER GENE THERAPY (2012)

Article Oncology

New Challenges in Endpoints for Drug Development in Advanced Melanoma

Antoni Ribas et al.

CLINICAL CANCER RESEARCH (2012)

Article Oncology

Tumor-specific CD4+ Melanoma Tumor-infiltrating Lymphocytes

Kevin M. Friedman et al.

JOURNAL OF IMMUNOTHERAPY (2012)

Article Medicine, Research & Experimental

Clinical scale rapid expansion of lymphocytes for adoptive cell transfer therapy in the WAVE® bioreactor

Robert P. T. Somerville et al.

JOURNAL OF TRANSLATIONAL MEDICINE (2012)

Article Oncology

Bioreactors get personal

Robert P. T. Somerville et al.

ONCOIMMUNOLOGY (2012)

Review Oncology

Cell transfer immunotherapy for metastatic solid cancer-what clinicians need to know

Steven A. Rosenberg

NATURE REVIEWS CLINICAL ONCOLOGY (2011)

Article Medicine, General & Internal

Treatment of metastatic melanoma with autologous CD4+T cells against NY-ESO-1

Naomi N. Hunder et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)